Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00006029 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: gemcitabine hydrochloride
DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: vinorelbine tartrate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]